Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2013 May 25

PMID 23704299

Citations 79

Authors

Samar M Said

Sanjeev Sethi

Anthony M Valeri

Nelson Leung

Lynn D Cornell

Mary E Fidler

Loren Herrera Hernandez

Julie A Vrana

Jason D Theis

Patrick S Quint

Ahmet Dogan

Samih H Nasr

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: The kidney is the organ most commonly involved in systemic amyloidosis. This study reports the largest clinicopathologic series of renal amyloidosis.

Design, Setting, Participants, & Measurements: This study provides characteristics of 474 renal amyloidosis cases evaluated at the Mayo Clinic Renal Pathology Laboratory from 2007 to 2011, including age, sex, serum creatinine, proteinuria, type of amyloid, and tissue distribution according to type.

Results: The type of amyloid was Ig amyloidosis in 407 patients (85.9%), AA amyloidosis in 33 (7.0%), leukocyte chemotactic factor 2 amyloidosis in 13 (2.7%), fibrinogen A α chain amyloidosis in 6 (1.3%), Apo AI, Apo AII, or Apo AIV amyloidosis in 3 (0.6%), combined AA amyloidosis/Ig heavy and light chain amyloidosis in 1 (0.2%), and unclassified in 11 (2.3%). Laser microdissection/mass spectrometry, performed in 147 cases, was needed to determine the origin of amyloid in 74 of the 474 cases (16%), whereas immunofluorescence failed to diagnose 28 of 384 light chain amyloidosis cases (7.3%). Leukocyte chemotactic factor 2 amyloidosis and Apo AI, Apo AII, or Apo AIV amyloidosis were characterized by diffuse interstitial deposition, whereas fibrinogen A α chain amyloidosis showed obliterative glomerular involvement. Compared with other types, Ig amyloidosis was associated with lower serum creatinine, higher degree of proteinuria, and amyloid spicules.

Conclusions: In the authors' experience, the vast majority of renal amyloidosis cases are Ig derived. The newly identified leukocyte chemotactic factor 2 amyloidosis form was the most common of the rarer causes of renal amyloidosis. With the advent of laser microdissection/mass spectrometry for amyloid typing, the origin of renal amyloidosis can be determined in >97% of cases.

Citing Articles

Computational Tools and Methods for the Study of Systemic Amyloidosis at the Clinical and Molecular Level.

Silvestre D, Brambilla F, Merlini G, Mauri P Methods Mol Biol. 2024; 2884:369-387.

PMID: 39716014 DOI: 10.1007/978-1-0716-4298-6_22.

Amyloidosis in Childhood: A Review of Clinical Features and Comparison with Adult Forms.

Zamarra G, Sandu M, Caione N, Di Pasquale G, Di Berardino A, Di Ludovico A J Clin Med. 2024; 13(22).

PMID: 39597824 PMC: 11594867. DOI: 10.3390/jcm13226682.

An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes.

Wendt R, Sobhani A, Diefenhardt P, Trappe M, Volker L Biomedicines. 2024; 12(10).

PMID: 39457572 PMC: 11504437. DOI: 10.3390/biomedicines12102259.

Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review.

He L, Zhou J, Wang M, Chen J, Liu C, Shi J Int Urol Nephrol. 2024; 57(2):517-533.

PMID: 39417966 PMC: 11772542. DOI: 10.1007/s11255-024-04236-w.

Kidney Disease in Systemic Amyloidosis: A Review of Amyloid, Amyloid Serum A Protein, Leukocyte Chemotactic Factor 2, and Transthyretin Amyloid.

Chowdhury R, Shah S, Latcha S, Lobato L Kidney360. 2024; 5(12):1925-1937.

PMID: 39356570 PMC: 11687988. DOI: 10.34067/KID.0000000600.

References

Kebbel A, Rocken C . Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol. 2006; 30(6):673-83. DOI: 10.1097/00000478-200606000-00002. View

Looi L, Cheah P . Histomorphological patterns of renal amyloidosis: a correlation between histology and chemical type of amyloidosis. Hum Pathol. 1997; 28(7):847-9. DOI: 10.1016/s0046-8177(97)90160-x. View

Benson M, Liepnieks J, Yazaki M, Yamashita T, Hamidi Asl K, Guenther B . A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene. Genomics. 2001; 72(3):272-7. DOI: 10.1006/geno.2000.6499. View

Nasr S, Said S, Valeri A, Sethi S, Fidler M, Cornell L . The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int. 2013; 83(3):463-70. DOI: 10.1038/ki.2012.414. View

Vrana J, Gamez J, Madden B, Theis J, Bergen 3rd H, Dogan A . Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009; 114(24):4957-9. DOI: 10.1182/blood-2009-07-230722. View

Novak L, Cook W, Herrera G, Sanders P . AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant. 2004; 19(12):3050-3. DOI: 10.1093/ndt/gfh503. View

Dikman S, Churg J, Kahn T . Morphologic and clinical correlates in renal amyloidosis. Hum Pathol. 1981; 12(2):160-9. DOI: 10.1016/s0046-8177(81)80103-7. View

Benson M, James S, Scott K, Liepnieks J, Kluve-Beckerman B . Leukocyte chemotactic factor 2: A novel renal amyloid protein. Kidney Int. 2008; 74(2):218-22. DOI: 10.1038/ki.2008.152. View

Eulitz M, Weiss D, Solomon A . Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci U S A. 1990; 87(17):6542-6. PMC: 54572. DOI: 10.1073/pnas.87.17.6542. View

10.

Murphy C, Wang S, Kestler D, Larsen C, Benson D, Weiss D . Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. Am J Kidney Dis. 2010; 56(6):1100-7. PMC: 2991509. DOI: 10.1053/j.ajkd.2010.08.013. View

11.

Verine J, Mourad N, Desseaux K, Vanhille P, Noel L, Beaufils H . Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol. 2007; 38(12):1798-809. DOI: 10.1016/j.humpath.2007.04.013. View

12.

Pepys M, Hawkins P, Booth D, Vigushin D, Tennent G, Soutar A . Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 1993; 362(6420):553-7. DOI: 10.1038/362553a0. View

13.

Merlini G, Bellotti V . Molecular mechanisms of amyloidosis. N Engl J Med. 2003; 349(6):583-96. DOI: 10.1056/NEJMra023144. View

14.

Okumura A, Saito T, Otani I, Kojima K, Yamada Y, Ishida-Okawara A . Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis. Arthritis Rheum. 2008; 58(2):413-21. DOI: 10.1002/art.23215. View

15.

Andrade C . A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952; 75(3):408-27. DOI: 10.1093/brain/75.3.408. View

16.

Nasr S, Colvin R, Markowitz G . IgG1 lambda light and heavy chain renal amyloidosis. Kidney Int. 2006; 70(1):7. DOI: 10.1038/sj.ki.5001545. View

17.

Shiiki H, Shimokama T, Yoshikawa Y, Toyoshima H, Kitamoto T, Watanabe T . Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features. Virchows Arch A Pathol Anat Histopathol. 1988; 412(3):197-204. DOI: 10.1007/BF00737143. View

18.

Gillmore J, Lachmann H, Rowczenio D, Gilbertson J, Zeng C, Liu Z . Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis. J Am Soc Nephrol. 2008; 20(2):444-51. PMC: 2637055. DOI: 10.1681/ASN.2008060614. View

19.

von Hutten H, Mihatsch M, Lobeck H, Rudolph B, Eriksson M, Rocken C . Prevalence and origin of amyloid in kidney biopsies. Am J Surg Pathol. 2009; 33(8):1198-205. DOI: 10.1097/PAS.0b013e3181abdfa7. View

20.

Sethi S, Gamez J, Vrana J, Theis J, Bergen 3rd H, Zipfel P . Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int. 2009; 75(9):952-60. PMC: 2738640. DOI: 10.1038/ki.2008.657. View